Company intelligence / Profile preview

Epikast

New York City, New York, United Statesepikast.com ↗

Ownership: Private
Development stage: Commercial

Overview

Epikast partners with biopharmaceutical companies to enhance stakeholder engagement—specifically with patients, physicians, caregivers, and other healthcare professionals. The company leverages behavioral science, data analytics, AI/machine learning technologies, and personalized communication strategies to improve the quality of interactions across all channels. It focuses on supporting drug launches and commercial models but does not itself conduct clinical trials or develop therapeutics[1][2][5].

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Epikast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epikast.

Explore the full profile